Skip to Content

Dr. Reeder and colleagues awarded highly competitive challenge grant as part of ARRA

Posted on Nov 2, 2009

Dr. Scott Reeder and colleagues were awarded a $1 million NIH grant through the American Recovery and Reinvestment Act to improve treatment of patients with hepatocellular carcinoma using innovative new MRI techniques. The team will use a non-invasive method that uses magnetic resonance imaging (MRI) to measure blood flow (perfusion) in hepatocellular carcinoma (HCC). The team will use the new method to determine whether anti-angiogenic drugs used to treat these tumors are effective. Currently, patients must undergo 2-3 months of anti-angiogenic therapy, which can be toxic and is expensive, in order to determine whether the drug is effective against the tumor. Using the new perfusion MRI methods, Dr. Reeder and his team aim to determine the efficacy of the drug in 2 days. In this way, the prolonged use of ineffective, toxic and expensive drugs can be avoided and alternative therapies pursued. Co-investigators include William Schelman, MD, PhD from Oncology, Sean Fain, PhD from Medical Physics and Radiology, and Wally Block, PhD from Biomedical Engineering and Radiology.

More news:

In Memoriam: William Werner Orrison Jr.

UW Radiology Training Program Named Best in 2017 Minnies Awards

The Inaugural Clark Cup Games

UWMF Medical Imaging Department Reaccredited As Diagnostic Imaging Center of Excellence

UW Radiology at AAPM 2017

UW Radiology Training Program Named Finalist in 2017 Minnies

Advances in Imaging: 3D Digital Breast Tomosynthesis

Dr. Mark Schiebler Joins Radiology Editorial Board

Dr. Broderick to Be Inaugurated President of Dane County Medical Society

Amy Romandine Wins UW Health Program Coordinator Excellence Award

Dr. Louis Hinshaw Wigs out for Fundraising Challenge

Dr. Pickhardt Receives Multi-Million Dollar NIH Grant

Last updated: 11/16/2017
Feedback, questions, or accessibility issues:
© 2017 The Board of Regents of the University of Wisconsin System